InsiderClue
Insiders · Profile

Kelderman Kim

Chief Executive Officer at Bio-Techne. Filing since 5 Feb 2021. CIK 0001739054

Company
Date
Role
Action
Shares
Amount
Of holding
TECH Bio-Techne
27 Jan 2025
Chief Executive Officer
Sold at will
13,392
$1.04M
25.6%
TECH Bio-Techne
19 Nov 2021
Pres. Diagnostics & Genom
Sold, plan not stated
500
$252.69K
100%
TECH Bio-Techne
22 Sep 2021
Pres. Diagnostics & Genom
Sold, plan not stated
822
$434.87K
100%
TECH Bio-Techne
9 Jun 2021
Pres. Diagnostics & Genom
Sold, plan not stated
811
$351.16K
100%
TECH Bio-Techne
25 May 2021
Pres. Diagnostics & Genom
Sold, plan not stated
845
$358.28K
51.0%
TECH Bio-Techne
5 Feb 2021
Pres. Diagnostics & Genom
Sold, plan not stated
823
$319.69K
49.3%
6 decisions on file.